Antibody Conjugated PLGA Nanoparticles for Targeted Delivery of Paclitaxel Palmitate: Efficacy and Biofate in a Lung Cancer Mouse Model
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Antibody Conjugated PLGA Nanoparticles for Targeted Delivery of Paclitaxel Palmitate: Efficacy and Biofate in a Lung Cancer Mouse Model
Authors
Keywords
-
Journal
Small
Volume 9, Issue 24, Pages 4221-4236
Publisher
Wiley
Online
2013-07-22
DOI
10.1002/smll.201301417
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Noncovalent Assembly of Targeted Carbon Nanovectors Enables Synergistic Drug and Radiation Cancer Therapy in Vivo
- (2012) Daisuke Sano et al. ACS Nano
- Vitamin E TPGS as a molecular biomaterial for drug delivery
- (2012) Zhiping Zhang et al. BIOMATERIALS
- Nanoparticles as delivery carriers for anticancer prodrugs
- (2012) Jia-You Fang et al. Expert Opinion on Drug Delivery
- Cetuximab in non-small-cell lung cancer
- (2012) Guido Carillio et al. Expert Review of Anticancer Therapy
- Anticancer nanomedicine and tumor vascular permeability; Where is the missing link?
- (2012) Sebastien Taurin et al. JOURNAL OF CONTROLLED RELEASE
- Analysis on the current status of targeted drug delivery to tumors
- (2012) Il Keun Kwon et al. JOURNAL OF CONTROLLED RELEASE
- Biodistribution Studies of Nanoparticles Using Fluorescence Imaging: A Qualitative or Quantitative Method?
- (2012) Yang Liu et al. PHARMACEUTICAL RESEARCH
- Targeted Delivery of Cisplatin to Lung Cancer Using ScFvEGFR-Heparin-Cisplatin Nanoparticles
- (2011) Xiang-Hong Peng et al. ACS Nano
- Squalene Based Nanocomposites: A New Platform for the Design of Multifunctional Pharmaceutical Theragnostics
- (2011) José L. Arias et al. ACS Nano
- Noncovalent Functionalization of Carbon Nanovectors with an Antibody Enables Targeted Drug Delivery
- (2011) Jacob M. Berlin et al. ACS Nano
- Physico-chemical parameters that govern nanoparticles fate also dictate rules for their molecular evolution
- (2011) Sandrine Dufort et al. ADVANCED DRUG DELIVERY REVIEWS
- The effect of hydrophilic chain length and iRGD on drug delivery from poly(ε-caprolactone)-poly(N-vinylpyrrolidone) nanoparticles
- (2011) Zhenshu Zhu et al. BIOMATERIALS
- Quantitative control of targeting effect of anticancer drugs formulated by ligand-conjugated nanoparticles of biodegradable copolymer blend
- (2011) Jing Zhao et al. BIOMATERIALS
- The Ligand Nanoparticle Conjugation Approach for Targeted Cancer Therapy
- (2011) Nour Karra et al. CURRENT DRUG METABOLISM
- Preparation and characterization of polymeric pH-sensitive STEALTH® nanoparticles for tumor delivery of a lipophilic prodrug of paclitaxel
- (2011) B.B. Lundberg INTERNATIONAL JOURNAL OF PHARMACEUTICS
- 2011 Focused Update of 2009 American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non–Small-Cell Lung Cancer
- (2011) Christopher G. Azzoli et al. JOURNAL OF CLINICAL ONCOLOGY
- Enhancement of surface ligand display on PLGA nanoparticles with amphiphilic ligand conjugates
- (2011) Jason Park et al. JOURNAL OF CONTROLLED RELEASE
- Targeted drug delivery to tumors: Myths, reality and possibility
- (2011) You Han Bae et al. JOURNAL OF CONTROLLED RELEASE
- EGFR-targeted stearoyl gemcitabine nanoparticles show enhanced anti-tumor activity
- (2011) Michael A. Sandoval et al. JOURNAL OF CONTROLLED RELEASE
- Cetuximab-labeled liposomes containing near-infrared probe for in vivo imaging
- (2011) Emma Portnoy et al. Nanomedicine-Nanotechnology Biology and Medicine
- Targeted human serum albumin nanoparticles for specific uptake in EGFR-Expressing colon carcinoma cells
- (2011) Karin Löw et al. Nanomedicine-Nanotechnology Biology and Medicine
- Pharmacokinetics and biodistribution of lonidamine/paclitaxel loaded, EGFR-targeted nanoparticles in an orthotopic animal model of multi-drug resistant breast cancer
- (2011) Lara Milane et al. Nanomedicine-Nanotechnology Biology and Medicine
- Designing Nanoconjugates to Effectively Target Pancreatic Cancer Cells In Vitro and In Vivo
- (2011) Jameel Ahmad Khan et al. PLoS One
- Targeted delivery of a cisplatin prodrug for safer and more effective prostate cancer therapy in vivo
- (2011) Shanta Dhar et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Characterization and Cancer Cell Specific Binding Properties of Anti-EGFR Antibody Conjugated Quantum Dots
- (2010) Junghan Lee et al. BIOCONJUGATE CHEMISTRY
- A strategy for precision engineering of nanoparticles of biodegradable copolymers for quantitative control of targeted drug delivery
- (2010) Yutao Liu et al. BIOMATERIALS
- Paclitaxel-loaded Pluronic nanoparticles formed by a temperature-induced phase transition for cancer therapy
- (2010) Keun Sang Oh et al. JOURNAL OF CONTROLLED RELEASE
- Functionalization of iron oxide nanoparticles with a versatile epoxy amine linker
- (2010) Michael Nickels et al. JOURNAL OF MATERIALS CHEMISTRY
- Interfacial Activity Assisted Surface Functionalization: A Novel Approach To Incorporate Maleimide Functional Groups and cRGD Peptide on Polymeric Nanoparticles for Targeted Drug Delivery
- (2010) Udaya S. Toti et al. MOLECULAR PHARMACEUTICS
- Nanostructured nanoparticles of self-assembled lipid pro-drugs as a route to improved chemotherapeutic agents
- (2010) Sharon M. Sagnella et al. Nanoscale
- Impact of Nanotechnology on Drug Delivery
- (2009) Omid C. Farokhzad et al. ACS Nano
- Targeted epidermal growth factor receptor nanoparticle bioconjugates for breast cancer therapy
- (2009) Sarbari Acharya et al. BIOMATERIALS
- Receptor-Targeted Nanoparticles for In vivo Imaging of Breast Cancer
- (2009) L. Yang et al. CLINICAL CANCER RESEARCH
- A quantitative evaluation of the molecular binding affinity between a monoclonal antibody conjugated to a nanoparticle and an antigen by surface plasmon resonance
- (2009) Nir Debotton et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Phase 1 and pharmacokinetic study of weekly docosahexaenoic acid-paclitaxel, Taxoprexin®, in resistant solid tumor malignancies
- (2008) Paula M. Fracasso et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Targeted Delivery of Gemcitabine to Pancreatic Adenocarcinoma Using Cetuximab as a Targeting Agent
- (2008) C. R. Patra et al. CANCER RESEARCH
- Squalenoylation Favorably Modifies the in Vivo Pharmacokinetics and Biodistribution of Gemcitabine in Mice
- (2008) L. H. Reddy et al. DRUG METABOLISM AND DISPOSITION
- Enhanced surface attachment of protein-type targeting ligands to poly(lactide-co-glycolide) nanoparticles using variable expression of polymeric acid functionality
- (2008) Paul A. McCarron et al. JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
- Overcoming the formulation obstacles towards targeted chemotherapy: In vitro and in vivo evaluation of cytotoxic drug loaded immunonanoparticles
- (2008) Nir Debotton et al. JOURNAL OF CONTROLLED RELEASE
- Tumor targetability and antitumor effect of docetaxel-loaded hydrophobically modified glycol chitosan nanoparticles
- (2008) Ho-Young Hwang et al. JOURNAL OF CONTROLLED RELEASE
- Method for Analysis of Nanoparticle Hemolytic Properties in Vitro
- (2008) Marina A. Dobrovolskaia et al. NANO LETTERS
- Precise engineering of targeted nanoparticles by using self-assembled biointegrated block copolymers
- (2008) F. Gu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Single Chain Epidermal Growth Factor Receptor Antibody Conjugated Nanoparticles for in vivo Tumor Targeting and Imaging
- (2008) Lily Yang et al. Small
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now